262 related articles for article (PubMed ID: 2537428)
1. Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.
Hertzberg RP; Caranfa MJ; Holden KG; Jakas DR; Gallagher G; Mattern MR; Mong SM; Bartus JO; Johnson RK; Kingsbury WD
J Med Chem; 1989 Mar; 32(3):715-20. PubMed ID: 2537428
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of 20(S)-camptothecin derivatives. A-ring-substituted 7-ethylcamptothecins and their E-ring-modified water-soluble derivatives.
Yaegashi T; Sawada S; Nagata H; Furuta T; Yokokura T; Miyasaka T
Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2518-25. PubMed ID: 7697767
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin.
Hautefaye P; Cimetière B; Pierré A; Léonce S; Hickman J; Laine W; Bailly C; Lavielle G
Bioorg Med Chem Lett; 2003 Aug; 13(16):2731-5. PubMed ID: 12873503
[TBL] [Abstract][Full Text] [Related]
4. Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.
Bailly C; Lansiaux A; Dassonneville L; Demarquay D; Coulomb H; Huchet M; Lavergne O; Bigg DC
Biochemistry; 1999 Nov; 38(47):15556-63. PubMed ID: 10569939
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.
Kingsbury WD; Boehm JC; Jakas DR; Holden KG; Hecht SM; Gallagher G; Caranfa MJ; McCabe FL; Faucette LF; Johnson RK
J Med Chem; 1991 Jan; 34(1):98-107. PubMed ID: 1846923
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of a series of lactone-opened camptothecin derivatives.
Zheng C; Li MZ; You TP; Tang WP; Lou LG
J Asian Nat Prod Res; 2019 Jan; 21(1):51-61. PubMed ID: 29063792
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of 20(S)-camptothecin derivatives: carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxycamptothecin.
Sawada S; Okajima S; Aiyama R; Nokata K; Furuta T; Yokokura T; Sugino E; Yamaguchi K; Miyasaka T
Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1446-50. PubMed ID: 1934165
[TBL] [Abstract][Full Text] [Related]
8. Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.
Lesueur-Ginot L; Demarquay D; Kiss R; Kasprzyk PG; Dassonneville L; Bailly C; Camara J; Lavergne O; Bigg DC
Cancer Res; 1999 Jun; 59(12):2939-43. PubMed ID: 10383158
[TBL] [Abstract][Full Text] [Related]
9. Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin.
Nicholas AW; Wani MC; Manikumar G; Wall ME; Kohn KW; Pommier Y
J Med Chem; 1990 Mar; 33(3):972-8. PubMed ID: 2155323
[TBL] [Abstract][Full Text] [Related]
10. The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity.
Bom D; Curran DP; Zhang J; Zimmer SG; Bevins R; Kruszewski S; Howe JN; Bingcang A; Latus LJ; Burke TG
J Control Release; 2001 Jul; 74(1-3):325-33. PubMed ID: 11489514
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity evaluation of a novel series of camptothecin analogs.
Lv J; Guo N; Wen SP; Teng YO; Ma MX; Yu P
J Asian Nat Prod Res; 2013; 15(8):867-74. PubMed ID: 23796391
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of 7-ethyl-9-alkyl derivatives of camptothecin.
Gao H; Zhang X; Chen Y; Shen H; Sun J; Huang M; Ding J; Li C; Lu W
Bioorg Med Chem Lett; 2005 Apr; 15(8):2003-6. PubMed ID: 15808456
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
Sugimori M; Ejima A; Ohsuki S; Uoto K; Mitsui I; Kawato Y; Hirota Y; Sato K; Terasawa H
J Med Chem; 1998 Jun; 41(13):2308-18. PubMed ID: 9632364
[TBL] [Abstract][Full Text] [Related]
14. Structural modifications of camptothecin and effects on topoisomerase I inhibition.
Crow RT; Crothers DM
J Med Chem; 1992 Oct; 35(22):4160-4. PubMed ID: 1331458
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues.
Li Q; Zu Y; Shi R; Yao L; Fu Y; Yang Z; Li L
Bioorg Med Chem; 2006 Nov; 14(21):7175-82. PubMed ID: 16870453
[TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Hsiang YH; Liu LF; Wall ME; Wani MC; Nicholas AW; Manikumar G; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Aug; 49(16):4385-9. PubMed ID: 2545341
[TBL] [Abstract][Full Text] [Related]
17. Chemical modification of an antitumor alkaloid, 20(S)-camptothecin: E-lactone ring-modified water-soluble derivatives of 7-ethylcamptothecin.
Sawada S; Yaegashi T; Furuta T; Yokokura T; Miyasaka T
Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):310-3. PubMed ID: 8500199
[TBL] [Abstract][Full Text] [Related]
18. Chemical modification of an antitumor alkaloid, 20(S)-camptothecin: glycosides, phosphates and sulfates of 7-ethyl-10-hydroxycamptothecin.
Yaegashi T; Nokata K; Sawada S; Furuta T; Yokokura T; Miyasaka T
Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):131-5. PubMed ID: 1576663
[TBL] [Abstract][Full Text] [Related]
19. Semi-synthesis and biological activity of gamma-lactones analogs of camptothecin.
Li M; Tang W; Zeng F; Lou L; You T
Bioorg Med Chem Lett; 2008 Dec; 18(24):6441-3. PubMed ID: 18986807
[TBL] [Abstract][Full Text] [Related]
20. Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
Zhao R; al-Said NH; Sternbach DL; Lown JW
J Med Chem; 1997 Jan; 40(2):216-25. PubMed ID: 9003520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
